01.03.2017
- In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...
29.07.2015
- French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...
